Swine Health and
Production
Errata
Listed in reverse chronological order by date of original publication:
Main RG, Dritz SS, Tokach MD, et al. Effects of weaning age on growing-pig
costs and revenue in a multi-site production system. J Swine Health Prod.
2005;13:189-197
There is an error in the Figure 1 legend. The last sentence of the legend
should read "In this modeled example, a 0.10-pig increase in total born on sow
litters and a 0.05% increase in preweaning mortality are recognized for each
1-day increase in lactation length."
The web and PDF versions have been corrected, Erratum published in November
and December (v13n6).
Mengeling
WL. The porcine reproductive and respiratory syndrome quandary. Part II: Vaccines
and vaccination strategy. J Swine Health Prod 2005:13:152-156.
The citation for
Reference #9 was erroneously reported. The correct citation is as follows:
Opriessnig T, Pallares FJ, Nilubol D, Vincpent AL, Thacker EL, Vaughn EM,
Roof M, Halbur PG. Genomic homology of ORF 5 gene sequence between modified
live vaccines and porcine reproductive and respiratory syndrome virus challenge
isolates is not predictive of vaccine efficacy. J Swine Health Prod.
In press.
The web version has been corrected; the PDF version has been amended.
Erratum published in July and August 2005 (v13n4).
Yoo BW, Choi SI,
Kim SH, et al. Immunostimulatory effects of an anionic alkali mineral complex
solution (Barodon®) on porcine lymphocytes. J Swine Health
Prod. 2002;10(6):265-270.
In Figure 1c, P values were incorrectly reported for weeks 11 and 13. The
correct P values are .02 for week 11, and .05 for week 13.
Figure 1d was incorrectly reported, and the correct graph is provided. The
proportions of non T/non B (N) cells were higher in the Barodon-treated group
than in the control group at Study Weeks 3 (P=.02), 11 (P=.02), and 13 (P=.03),
but not at Study Week 8.
The web version has been corrected; the PDF has been amended. Erratum published
in January and February 2003 (v11n1).
Otake S, Dee SA,
Rossow KD, Deen J, Joo HS, Molitor TW, Pijoan C. Transmission of porcine reproductive
and respiratory syndrome virus by fomites (boots and coveralls). J Swine
Health Prod. 2002;10(2):59-65.
The following errata were present in the original but have been corrected in
this version (April 15 2002):
· The credentials of one of the authors, Dr John Deen, were erroneously
reported as "DVM, PhD, Diplomate ACVM". Dr Deen's correct credentials
are "DVM, PhD, Diplomate ABVP".
· In Figure 1, page 61, the letter designates on the diagrams for
the Alternative protocol and the Standard protocol were inadvertently reversed
on the right side of the figure. The designate for the Standard protocol (Group
4) should be the letter "C", and for the Alternative protocol (Group
5), the designate should be the letter "D".
Desrosiers R, Boutin
M. An attempt to eradicate porcine reproductive and respiratory syndrome virus
(PRRSV) after an outbreak in a breeding herd: eradication strategy and persistence
of antibody titers in sows. 2002;10(1):23-25.
On page 24, last paragraph of the Results section, it was reported in error
that spleen samples were tested by PCR: spleen samples were not tested.
On page 24, second column, third paragraph, the following sentence is inaccurate: "In
a study by Wills et al, experimentally infectedpigs were able to transmit PRRSV
for no more than 69 days." In the reported study, Wills et al found that "infected
pigs were found to be contagious through day 62, but not after day 69."
The web version has been corrected; the PDF has not. Erratum published
in March and April 2002 (v10 n2).
Mathew AG, Beckman
MA, Saxton AM. A comparison of antibiotic resistance in bacteria isolated from
swine herds in which antibiotics were used or excluded. J Swine Health
Prod. 2001;9(3):125-129.
References to Escherichia coli O157:H7 in this article were reported
in error. In all instances, isolates were confirmed to be E coli O157,
but testing for the H7 antigen was not performed.
Also in this article, the symbols ">=" and "<=" were
inadvertently deleted during the printing process. The corrected information
follows.
Materials and methods, page 126, second column: Resistance was determined
at the following breakpoints: ampicillin, >=32 mg per mL; ceftiofur, >=8
mg per mL; gentamicin and oxytetracycline, >=16 mg per mL; and sulfamethazine, >=512
mg per mL.
Results, page 127, third paragraph: Resistance to ceftiofur tended to be low
for all isolates, and even though differences occurred in MICs between the
two herd types in isolates from the 4.5-kg pigs, all isolates were still within
the range (<=2 mg per mL) considered to be susceptible to that drug (Figure
5).
Results, page 128, first paragraph: Approximately 2% of salmonellae from AU
farms were determined to be resistant to oxytetracycline, on the basis of human-derived
breakpoints (MIC>=16 mg per mL), whereas no resistant isolates were cultured
from the AF herd.
Discussion, page 128, last lines: The greater MICs noted for ampicillin in
E coli from younger animals were primarily due to larger numbers of resistant
organisms with breakpoints >=128 mg per mL.
Hurd HS, Bush EJ, Losinger W, et al. Outbreaks of
porcine reproductive failure: Report on a collaborative field investigation. J Swine
Health Prod. 2001;9(3):103-108.
In this article, the symbol ">=" was inadvertently deleted during
the printing process. The corrected information follows.
Results, page 106, second column, third paragraph: A sample was considered
positive if the sample-to-positive ratio was >=0.4.
Table 2, footnote "a": HerdCheck(R) (ELISA), sample:positive ratio >0.4
considered positive.
Charles SD, Abraham
AS, Trigo ET, et al. Reduced shedding and clinical signs of Salmonella Typhimurium
in nursery pigs vaccinated with a Salmonella Choleraesuis vaccine. Swine Health
Prod. 2000;8(3):107112.
In Figure 5, page 111, the correct value for ICJ, Study 3, VACC-CHAL(21) is
5%, not 50%. The corrected figure appears here; the
PDF has been updated as well.

Amass SF, Clark LK.
Biosecurity considerations for pork production units. Swine Health Prod.
1999;7(5):217-228.
Cleaning and disinfection, Vesicular exanthema virus, page 225: The disinfectants
that inactivate this virus were reported in error. The correct information
follows:
Blackwell93 reported VEV was inactivated after 2 minutes of exposure
to 0.1% sodium hypochlorite, 2% sodium metasilicate, 5% sodium carbonate, 2%
sodium hydroxide, 2% citric acid, 5% acetic acid, and 5% phenol.
Marsteller TA, Fenwick
B. Actinobacillus pleuropneumoniae disease and serology. 1999; 7(4): 161-165.
Several errors were published in Table 1 (page 163). Biochemical and bacterial
growth characteristics are important in the classification of bacteria. However,
the enzymes used in biochemical reactions can be up-regulated or down-regulated
by the bacteria and may cause confusion with bacterial classification. Polymerase
chain reaction, which uses the DNA of bacteria, may be important in classifying
any bacteria when confusion exists concerning bacterial biochemical reactions.
Actinobacillus pleuropneumoniae is especially noted for its variable biochemical
reactions.21 The corrected Table 1 appears here.

[Correction printed in v7n6. The online HTML version
incorporates this erratum, as does the PDF.]
del Castillo, Jerome.
Pharmacokinetic modeling of in-feed tetracyclines in pigs using a meta-analytic
compartmental approach. 1998;6(5):189202.
Some text was inadvertently deleted from the bottom of page 195. The affected
paragraphs should read:
As expected, these models were not able to predict plasma concentrations
of OTC in fasted piglets dosed with a medicated drench.22,23 Plasma
OTC concentrations found with medicated drench administration to fasted22,23 or
fed22 pigs were considerably higher than both concentrations predicted
with the equations and those from their experiments using medicated feeds.25,26 Intestinal
absorption of OTC is reduced by the presence of food.5
Our model for CTC was also in close agreement to observations reported by
Andrews, et al.18 in pigs that were challenged with Pasteurella
multocida and then received CTC-medicated feed. This agreement is somewhat
surprising, because the disease challenge is known to modify drug disposition
in animals.1
[Correction printed in v6n6. The online HTML
version did not have this flaw; the PDF version
has been corrected. A separate PDF containing only the corrected
page 195 is here.]
Wu CC, et al., Testing
antimicrobial susceptibility against Mycoplasma hyopneumoniae in
vitro. 1997;5(6):227230.
In the results section (page 229), the MICs for Lincomycin were reported as <=
0.5 µg per mL for 93% of the isolates. This value is incorrect. The correct
MIC for those 93% of the isolates is 1 µg per mL.
The value reported in the summary (page 227) is correct as it stands.
The author adds the following comment:
"We are aware of the extralabel prohibition against fluoroquinolones
maintained by the CVM. Our intent in including this compound in our study
was not to recommend to practitioners that a quinolone be used in swine for
Mycoplasma, but rather to provide in vitro data to suggest further developmental
work only."
Lane D, et al. Using partial
budgets to analyze selected management practices associated with reduced
preweaning mortality. 1997;5(3):95-102.
The capital recovery charges formula given on p. 97 is incorrect. The correct
formula appears below:

where:
i = annual interest rate
n = number of years of useful life
BV = beginning market value
EV = ending market value
[Correction printed in v5n5]
On page 61, the vertical axis labels for Figure 2 (PRRSV serology) are incorrect.
The prevalence of pigs at 21 days of age is 76.6% for those with antibody titers <16
and 6.6% for those with antibody titers of 16.The corrected figure appears here. [Correction printed in v5n4.]
The values given in Table 4 (Codex, Japanese, and United States Maximum Residue
Limits for oxytetracycline and chlortetracycline) were misreported. The values
in the table should be [micro]g per kg, not mg per kg as stated.
Since the release of the January issue of Swine Health and Production,
the United States Food and Drug Administration has published amended residue
limits. The new limits are reported in Table
4. [Correction printed in v5n4.]
Kirkwood, R,
et al. The effect of dose and route of administration of prostaglandin
F2[alpha] on the parturient response of sows. 1996; 4(3):123-127.
The results reported for the "late" sows (cumulative farrowing 8-48
hours after treatment) in Figure 2 were reported incorrectly. The correct values
are as follows:
88 [micro]g V = 29.1%
88 [micro]g P = 33.8%
44 [micro]g V = 21.9%
44 [micro]g P = 22.3%
[Correction printed in v5n2.]
|